Centessa Pharmaceuticals (CNTA) Capital Expenditures (2021 - 2025)
Centessa Pharmaceuticals (CNTA) reported Capital Expenditures of $11000.0 for Q4 2025, down 95.3% on a QoQ basis from $234000.0 in Q3 2025.
Centessa Pharmaceuticals (CNTA) has 5 years of Capital Expenditures data on file, last reported at $11000.0 in Q4 2025.
- Quarterly Capital Expenditures changed N/A year-over-year to $11000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $279000.0 (up 720.59% YoY) and the FY2025 annual result came in at $371000.0, up 991.18% from the prior year.
- Capital Expenditures slipped to $11000.0 in Q4 2025 per CNTA's latest filing, from $234000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $652000.0 in Q4 2022 and bottomed at $10000.0 in Q2 2023.
- The 5-year median for Capital Expenditures is $43000.0 (2023), against an average of $118066.7.
- The widest annual swing landed in 2022, when Capital Expenditures surged 918.75%; it then plunged 95.71% in 2023.
- Tracing CNTA's Capital Expenditures over 5 years: stood at $64000.0 in 2021, then surged by 918.75% to $652000.0 in 2022, then sank by 95.71% to $28000.0 in 2023, then climbed by 21.43% to $34000.0 in 2024, then tumbled by 67.65% to $11000.0 in 2025.
- Per Business Quant, the three latest CNTA Capital Expenditures figures stand at $11000.0 (Q4 2025), $234000.0 (Q3 2025), and $34000.0 (Q3 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 133.40 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 230.60 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 21.83 Mn |
| 10 | Centessa Pharmaceuticals | 6.12 Bn | 6.12 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 11,000.00 |
| Dec 31, 2025 | 11,000.00 |
| Sep 30, 2025 | 234,000.00 |
| Sep 30, 2025 | 234,000.00 |
| Sep 30, 2024 | 34,000.00 |
| Sep 30, 2024 | 34,000.00 |
| Dec 31, 2023 | 28,000.00 |
| Dec 31, 2023 | 28,000.00 |
| Sep 30, 2023 | 43,000.00 |
| Sep 30, 2023 | 43,000.00 |
| Jun 30, 2023 | 10,000.00 |
| Jun 30, 2023 | 10,000.00 |
| Mar 31, 2023 | 88,000.00 |
| Mar 31, 2023 | 88,000.00 |
| Dec 31, 2022 | 652,000.00 |
| Dec 31, 2022 | 652,000.00 |
| Sep 30, 2022 | 16,000.00 |
| Sep 30, 2022 | 16,000.00 |
| Jun 30, 2022 | 229,000.00 |
| Jun 30, 2022 | 229,000.00 |
| Mar 31, 2022 | 240,000.00 |
| Mar 31, 2022 | 240,000.00 |
| Dec 31, 2021 | 64,000.00 |
| Dec 31, 2021 | 64,000.00 |
| Sep 30, 2021 | 48,000.00 |
| Sep 30, 2021 | 48,000.00 |
| Jun 30, 2021 | 37,000.00 |
| Jun 30, 2021 | 37,000.00 |
| Mar 31, 2021 | 37,000.00 |
| Mar 31, 2021 | 37,000.00 |